Wataru Shimizu

Jun 1, 2023 | jacc.org | Wataru Shimizu |Takeshi Yamashita |Masaharu Akao |Hirotsugu Atarashi

JACC Journals › JACC: Asia › Archives › Vol. 3 No. 3_Part_2 AbstractBackgroundAdvancing age, decreasing renal function, and atrial fibrillation are strongly associated. Real-world evidence of direct oral anticoagulant (DOAC) use among elderly patients ≥75 years of age with nonvalvular atrial fibrillation and renal dysfunction is limited. ObjectivesThis study sought to assess 2-year outcomes and anticoagulant treatment, stratified by renal function.